Resistance to anti-cancer treatments is a critical and widespread health issue that has
brought serious impacts on lives, the economy and public policies. Mounting research has …

Colorectal cancer (CRC) is the third most common malignant tumor in humans.
Chemotherapy is used for the treatment of CRC. However, the effect of chemotherapy …

Simple Summary Chemotherapy, radiotherapy and molecularly targeted therapy could
improve the prognosis of colorectal cancer (CRC) patients. Recently, immunotherapy …

A significant obstacle to treating cancer is multidrug resistance (MDR), which is the capacity
of cancerous cells to develop resistance to both traditional and cutting-edge …

Colorectal cancer (CRC) is a common malignancy with high morbidity and mortality
worldwide. To date, chemotherapy plays an important role in the treatment of CRC patients …

Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies,
Volume Eight, summarizes the molecular mechanisms of drug resistance in colorectal …

A number of successful systemic therapies are available for the treatment of disseminated
cancers. However, tumor response is often transient, and therapy frequently fails due to …

Resistance to chemotherapy limits the effectiveness of current cancer therapies, including
those used to treat colorectal cancer, which is the second most common cause of cancer …

Colorectal cancer (CRC) persists as one of the most prevalent and deadly tumor types in
both men and women worldwide. This is in spite of widespread, effective measures of …

Colorectal cancer (CRC) is the third most diagnosed malignancy and a major leading cause
of cancer-related deaths worldwide. Despite advances in therapeutic regimens, the number …